Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) EPS (Basic) (2019 - 2025)

Volitionrx's EPS (Basic) history spans 9 years, with the latest figure at $0.01 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 101.08% year-over-year to $0.01; the TTM value through Dec 2025 reached -$0.15, up 84.21%, while the annual FY2025 figure was -$0.22, 29.03% up from the prior year.
  • EPS (Basic) reached $0.01 in Q4 2025 per VNRX's latest filing, up from -$0.0 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.01 in Q4 2025 to a low of -$10.08 in Q4 2023.
  • Average EPS (Basic) over 5 years is -$0.63, with a median of -$0.1 recorded in 2024.
  • Peak YoY movement for EPS (Basic): surged 101.53% in 2022, then crashed 9832.94% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at -$0.15 in 2021, then soared by 100.85% to $0.0 in 2022, then crashed by 794669.9% to -$10.08 in 2023, then skyrocketed by 93.4% to -$0.67 in 2024, then surged by 101.08% to $0.01 in 2025.
  • Per Business Quant, the three most recent readings for VNRX's EPS (Basic) are $0.01 (Q4 2025), -$0.0 (Q3 2025), and $0.0 (Q2 2025).